The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation

Breast Cancer Research and Treatment

Volumn 125, Issue 2, 2011, Pages 363-375

  Yao, Hongren ^a   Veine, Donna M ^a   Fay, Kevin S ^a   Staszewski, Evan D ^a   Zeng, Zhao Zhu ^a   Livant, Donna L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Breast cancer; Extravasation; Integrin fibronectin receptor; Invasion; Lung metastasis; MMP 1

Indexed keywords

ACETYLPROLYLHISTIDYLSERYLCYSTEINYLASPARAGYLGLYCYLGLYCINE MULTIANGENIC PEPTIDE; ANTINEOPLASTIC AGENT; INTERSTITIAL COLLAGENASE; N ACETYLPROLYLHISTIDYLSERYLCYSTEINYLASPARAGINE AMIDE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DENDRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA5BETA1; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 1; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGOPEPTIDES;

EID: 78650990964     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0826-y     Document Type: Article

References (58)

1. A Sanchez-Munoz E Perez-Ruiz N Ribelles A Marquez E Alba 2008 Maintenance treatment in metastatic breast cancer Expert Rev Anticancer Ther 8 1907 1912 10.1586/14737140.8.12.1907 1:CAS:528:DC%2BD1cXhsVKgs7vN 10.1586/14737140.8.12. 1907 19046111
2. EA Perez 2009 Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer Breast Cancer Res Treat 114 195 201 10.1007/s10549-008-0005-6 1:CAS:528:DC%2BD1MXhsFWnu7o%3D 10.1007/s10549-008-0005-6 18443902
3. A Chan 2009 Antiangiogenic therapy for metastatic breast cancer: current status and future directions Drugs 69 167 181 10.2165/00003495-200969020-00003 1:CAS:528:DC%2BD1MXkvFClsLY%3D 10.2165/00003495-200969020-00003 19228074
4. SH Giordano AU Buzdar TL Smith SW Kau Y Yang GN Hortobagyi 2004 Is breast cancer survival improving? Cancer 100 44 52 10.1002/cncr.11859 10.1002/cncr.11859 14692023 (Pubitemid 37553538)
5. MJ Higgins AC Wolff 2008 Therapeutic options in the management of metastatic breast cancer Oncology 22 614 623 18561551 (discussion 623, 627-629)
6. ZZ Zeng H Yao ED Staszewski KF Rockwood SM Markwart KS Fay AC Spalding DL Livant 2009 Alpha(5)beta(1) integrin ligand PHSRN induces invasion and alpha(5) mRNA in endothelial cells to stimulate angiogenesis Transl Oncol 2 8 20 19252747
7. YF Jia SM Markwart KF Rockwood KM Woods-Ignatoski SP Ethier DL Livant 2004 Integrin fibronectin receptors in MMP-1 dependent invasion by breast cancer and mammary epithelial cells Cancer Res 64 8674 8681 1:CAS:528: DC%2BD2cXhtVCjs7rO 10.1158/0008-5472.CAN-04-0069 15574776 (Pubitemid 39552082)
8. DL Livant RK Brabec KJ Pienta DL Allen K Kurachi S Markwart A Upadhyaya 2000 Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma Cancer Res 60 309 320 1:CAS:528: DC%2BD3cXhtVahs7Y%3D 10667582
9. Z-Z Zeng YF Jia NJ Hahn SM Markwart KF Rockwood DL Livant 2006 Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1 dependent invasion by metastatic prostate cancer cells Cancer Res 66 8091 8099 1:CAS:528: DC%2BD28XotFWqtLo%3D 10.1158/0008-5472.CAN-05-4400 16912186 (Pubitemid 44299175)
10. DE White WJ Muller 2007 Multifaceted roles of integrins in breast cancer metastasis J Mammary Gland Biol Neoplasia 12 135 142 10.1007/s10911-007-9045-5 10.1007/s10911-007-9045-5 17602286 (Pubitemid 47215431)
11. FL Miles FL Pruitt KL van Golen CR Cooper 2008 Stepping out of the flow: capillary extravasation in cancer metastasis Clin Exp Metastasis 25 305 324 10.1007/s10585-007-9098-2 1:CAS:528:DC%2BD1cXptVSqu7o%3D 10.1007/s10585-007- 9098-2 17906932 (Pubitemid 351748980)
12. M Guba AK Bosserhoff M Steinbauer C Abels M Anthuber R Buettner KW Jauch 2000 Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo Br J Cancer 83 1216 1222 10.1054/bjoc.2000.1424 1:CAS:528:DC%2BD3cXot1Sqsbs%3D 10.1054/bjoc.2000.1424 11027436
13. N Matsuura W Puzon-McLaughlin A Irie Y Morikawa K Kakudo Y Takada 1996 Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells Am J Pathol 148 55 61 1:CAS:528: DyaK28Xitlahs7Y%3D 8546226
14. DL Livant K Kurachi DL Allen Y Wu R Haaseth P Andrews SP Ethier S Markwart 2000 The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice J Clin Invest 105 1537 1545 1:CAS:528:DC%2BD3cXjvFWmtro%3D 10.1172/JCI8527 10841512
15. S Aota T Nagai KM Yamada 1991 Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis J Biol Chem 266 15938 15943 1:CAS:528:DyaK3MXmtVCgu7g%3D 1874740
16. AP Mould JA Askari SI Aota KM Yamada A Irie Y Takada HJ Mardon MJ Humphries 1997 Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit J Biol Chem 272 17283 17292 1:CAS:528:DyaK2sXksFOnt7o%3D 10.1074/jbc.272.28.17283 9211865 (Pubitemid 27311152)
17. ME Cianfrocca KA Kimmel J Gallo T Cardoso MM Brown G Hudes N Lewis L Weiner GN Lam SC Brown DE Shaw AP Mazar RB Cohen 2006 Phase I trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2) a beta integrin antagonist, in patients with solid tumours Br J Cancer 94 1621 1626 1:CAS:528: DC%2BD28XltVOmurg%3D 16705310
18. P Khalili A Arakelian G Chen ML Plunkett I Beck GC Parry F Donate DE Shaw AP Mazar SA Rabbani 2006 A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo Mol Cancer Ther 5 2271 2280 1:CAS:528:DC%2BD28Xps1ynsL0%3D 10.1158/1535-7163.MCT-06-0100 16985061 (Pubitemid 44530464)
19. O Stoeltzing W Liu N Reinmuth F Fan GC Parry AA Parikh MF McCarty CD Bucana AP Mazar LM Ellis 2003 Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice Int J Cancer 104 496 503 1:CAS:528:DC%2BD3sXisVejt7Y%3D 10.1002/ijc.10958 12584749 (Pubitemid 36323922)
20. KL van Golen LW Bao GJ Brewer KJ Pienta JM Kamradt DL Livant SD Merajver 2002 Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma Neoplasia 4 373 379 10.1038/sj.neo.7900258 12192595 (Pubitemid 34976952)
21. R Cailleau M Olive QV Cruciger 1978 Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization In Vitro 14 911 915 1:STN:280:DyaE1M%2FoslCqtQ%3D%3D 10.1007/BF02616120 730202
22. KL van Golen S Davies ZF Wu Y Wang CD Bucana H Root S Chandrasekharappa M Strawderman SP Ethier SD Merajver 1999 A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype Clin Cancer Res 5 2511 2519 10499627
23. E Kaiser RL Colescott CD Bossinger PI Cook 1970 Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides Anal Biochem 34 595 598 1:CAS:528:DyaE3cXhtVWjur0%3D 10.1016/0003-2697(70)90146-6 5443684
24. Remmer H, Fields G (2000) Chemical synthesis of peptides. In: Reid RE (ed) Peptide and protein drug analysis. Marcel Dekker, Inc., New York, pp 133-169
25. Grant GA (2002) Evaluation of the synthetic product. In: Grant GA (ed) Synthetic peptides: a user's guide, 2nd edn. Oxford University Press, Oxford, pp 220-291
26. NS DeSilva I Ofek EC Crouch 2003 Interactions of surfactant protein D with fatty acids Am J Respir Cell Mol Biol 29 757 770 10.1165/rcmb.2003-0186OC 1:CAS:528:DC%2BD3sXhtVSgs7zO 10.1165/rcmb.2003-0186OC 12816736 (Pubitemid 38045944)
27. TC Chou P Talalay 1984 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 27 55 1:CAS:528:DyaL2cXktlaksLk%3D 10.1016/0065-2571(84)90007-4 6382953
28. H Ren X Tan Y Dong A Giese TC Chou N Rainov B Yang 2009 Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells Basic Clin Pharmacol Toxicol 104 241 252 10.1111/j.1742-7843.2008.00371.x 1:CAS:528:DC%2BD1MXivF2rsLc%3D 10.1111/j.1742-7843.2008.00371.x 19159435
29. P Godement J Vanselow S Thanos F Bonhoeffer 1987 A study in developing visual systems with a new method of staining neurones and their processes in fixed tissue Development 101 697 713 1:STN:280:DyaL1M%2FjtVaqsQ%3D%3D 2460302
30. Heimer L, Záborszky L (1989) Neuroanatomical tract-tracing methods, 2: recent progress. Plenum, New York
31. A Collazo M Bronner-Fraser SE Fraser 1993 Vital dye labelling of Xenopus laevis trunk neural crest reveals multipotency and novel pathways of migration Development 118 363 376 1:STN:280:DyaK2c%2FjvVKrsw%3D%3D 7693414
32. DP Kuffler 1990 Long-term survival and sprouting in culture by motoneurons isolated from the spinal cord of adult frogs J Comp Neurol 302 729 738 10.1002/cne.903020405 1:STN:280:DyaK3M7osFKlsw%3D%3D 10.1002/cne.903020405 1707066
33. A Peled O Kollet T Ponomaryov I Petit S Franitza V Grabovsky MM Slav A Nagler O Lider R Alon D Zipori T Lapidot 2000 The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice Blood 95 3289 3296 1:CAS:528:DC%2BD3cXjsl2isrw%3D 10828007
34. H Yao EJ Dashner CM van Golen KL van Golen 2006 RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility Oncogene 25 2285 2296 1:CAS:528:DC%2BD28XjsVWku70%3D 10.1038/sj.onc.1209260 16314838
35. HS Baldwin HM Shen HC Yan HM DeLisser A Chung C Mickanin T Trask NE Kirschbaum PJ Newman SM Albelda, et al. 1994 Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development Development 120 2539 2553 1:CAS:528:DyaK2MXmvVGgug%3D%3D 7956830
36. J Luo P Guo K Matsuda N Truong A Lee C Chun SY Cheng M Korc 2001 Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo Int J Cancer 92 361 369 10.1002/ijc.1202 1:CAS:528:DC%2BD3MXjtVWitbo%3D 10.1002/ijc.1202 11291072 (Pubitemid 32249712)
37. GP Gupta J Perk S Acharyya P de Candia V Mittal K Todorova-Manova WL Gerald E Brogi R Benezra J Massague 2007 ID genes mediate tumor reinitiation during breast cancer lung metastasis Proc Natl Acad Sci USA 104 19506 19511 10.1073/pnas.0709185104 1:CAS:528:DC%2BD1cXisVOgsw%3D%3D 10.1073/pnas.0709185104 18048329
38. MA Rowland-Goldsmith H Maruyama K Matsuda T Idezawa M Ralli S Ralli M Korc 2002 Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis Mol Cancer Ther 1 161 167 1:CAS:528:DC%2BD38XpsFalug%3D%3D 12467210
39. FW Orr HH Wang RM Lafrenie S Scherbarth DM Nance 2000 Interactions between cancer cells and the endothelium in metastasis J Pathol 190 310 329 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P 1:CAS:528:DC%2BD3cXitFyhsr4%3D 10.1002/(SICI)1096-9896(200002)190:3<310::AID- PATH525>3.0.CO;2-P 10685065 (Pubitemid 30141377)
40. TS Lawrence MA Davis J Maybaum SK Mukhopadhyay PL Stetson DP Normolle PE McKeever WD Ensminger 1992 The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer Cancer Res 52 3698 3704 1:CAS:528:DyaK38XltVOns7o%3D 1617642
41. GN Hortobagyi 1998 Treatment of breast cancer N Engl J Med 339 974 984 1:CAS:528:DyaK1cXmslCitrY%3D 10.1056/NEJM199810013391407 9753714 (Pubitemid 28455101)
42. PA Greenberg GN Hortobagyi TL Smith LD Ziegler DK Frye AU Buzdar 1996 Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer J Clin Oncol 14 2197 2205 1:CAS:528:DyaK28XltFSqsLk%3D 8708708
43. BT McGrogan B Gilmartin DN Carney A McCann 2008 Taxanes, microtubules and chemoresistant breast cancer Biochim Biophys Acta 1785 96 132 10.1016/j.bbcan.2007.10.004 1:CAS:528:DC%2BD1cXkvFWlu78%3D 18068131
44. AJ Chien MM Moasser 2008 Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired Semin Oncol 35 S1 S14 10.1053/j.seminoncol.2008.02.010 1:CAS:528:DC%2BD1cXmtFOrtr0%3D 10.1053/j.seminoncol.2008.02.010 18410794 (Pubitemid 351503598)
45. P Huhtala MJ Humphries JB McCarthy PM Tremble Z Werb CH Damsky 1995 Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin J Cell Biol 129 867 879 1:CAS:528:DyaK2MXlt1WrsLw%3D 10.1083/jcb.129.3.867 7537277
46. DL Livant 2005 Targeting invasion as a therapeutic strategy for the treatment of cancer Curr Cancer Drug Targets 5 489 503 1:CAS:528: DC%2BD2MXhtFCgsLnL 10.2174/156800905774574002 16305346 (Pubitemid 41502561)
47. D Greiling RA Clark 1997 Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix J Cell Sci 110 861 870 1:CAS:528:DyaK2sXjtFeku7s%3D 9133673
48. F Grinnell M Zhu 1994 Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin J Invest Dermatol 103 155 161 1:CAS:528:DyaK2MXotFyhuw%3D%3D 10.1111/1523-1747. ep12392625 8040604
49. KM Woods-Ignatoski NK Grewal SM Markwart DL Livant SP Ethier 2003 p38 MAPK induces cell surface α4 integrin down-regulation to facilitate erbB-2 mediated invasion Neoplasia 5 128 134 1:CAS:528:DC%2BD3sXjt1ykt78%3D 12659685
50. KM Woods Ignatoski DL Livant S Markwart NK Grewal SP Ethier 2003 The role of phosphatidylinositol 3'-kinase and its downstream signals in erbB-2-mediated transformation Mol Cancer Res 1 551 560 1:CAS:528:DC%2BD3sXjvVSltLc%3D 12754302
51. KM Woods-Ignatoski T Maehama SM Markwart JE Dixon DL LIvant SP Ethier 2000 ERBB-2 overexpression confers P1 3′ kinase-dependent invasion capacity on human mammary epithelial cells Br J Can 82 666 674 10.1054/bjoc.1999.0979
52. DF Mosher 1984 Physiology of fibronectin Ann Rev Med 35 561 575 1:CAS:528:DyaL2cXitVKqsr4%3D 10.1146/annurev.me.35.020184.003021 6326663
53. E Ruoslahti EG Hayman M Pierschbacher E Engvall 1982 Fibronectin: purification, immunochemical properties, and biological activities Methods Enzymol 82 803 831 1:CAS:528:DyaL38XhsFOmsrc%3D 10.1016/0076-6879(82)82103-4 7078457
54. G Fassina A Corti G Cassani 1992 Affinity enhancement of complementary peptide recognition Int J Pept Protein Res 39 549 556 1:CAS:528: DyaK3sXkt1Sltrw%3D 10.1111/j.1399-3011.1992.tb00287.x 1399275
55. P Sinnis P Clavijo D Fenyo BT Chait C Cerami V Nussenzweig 1994 Structural and functional properties of region II-plus of the malaria circumsporozoite protein J Exp Med 180 297 306 1:CAS:528:DyaK2cXltVKitrc%3D 10.1084/jem.180.1.297 8006589 (Pubitemid 24181078)
56. E Carlier K Mabrouk M Moulard Z Fajloun H Rochat M De Waard JM Sabatier 2000 Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loop J Pept Res 56 427 437 1:CAS:528:DC%2BD3MXivVSn 10.1034/j.1399-3011.2000. 00815.x 11152302
57. N Yahi JM Sabatier S Baghdiguian F Gonzalez-Scarano J Fantini 1995 Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line J Virol 69 320 325 1:CAS:528:DyaK2MXislWrt7k%3D 7983725
58. M Nomizu K Yamamura HK Kleinman Y Yamada 1993 Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis Cancer Res 53 3459 3461 1:CAS:528:DyaK2cXitlSktg%3D%3D 8339246